Literature DB >> 117951

Clinical correlations between long-term (IgE) and short-term (IgG S-TS) anaphylactic antibodies in atopic and 'non-atopic' subjects with respiratory allergic disease.

J Pepys, W E Parish, B Stenius-Aarniala, L Wide.   

Abstract

The sera of atopic and non-atopic persons with allergic pulmonary disorders were examined for long-term sensitizing, IgE and short-term sensitizing heat-stable (S-TS) antibodies which were present separately or together in the sera of some patients sensitive to antigens such as budgerigar serum proteins and Aspergillus funigatus. In fourteen atopic patients with extrinsic asthma, six had both types of antibody to common allergens, and of nine non-atopic patients with crytogenic (intrinsic) asthma, four had only heat-stable short-term sensitizing antibodies. The sera of atopic subjects with type I prick test reactions and positive RAST's, showed specific IgE antibody by baboon PCA tests to budgerigar serum proteins, A. funigatus, Timothy grass pollen extract and hen egg extract, and not to Dermatophagoides farinae, possibly because of naturally occurring mite antibodies in the baboon. The sera of non-atopic asthmatics, who had given negative prick test but positive immediate, dual or late intracutaneous tests, and only late asthmatic reactions, contained precipitins in most cases and gave little or no RAST reaction. On baboon PCA these sera contained either, S-TS antibody alone, or S-TS plus long-term sensitizing antibody, or long-term sensitizing antibody alone. Some of the sera with long-term sensitizing antibody contained blocking antibody which could diffuse away in the 24 hr delay for the baboon PCA test and could also be responsible for the negative RAST. Tests with insoluble anti-IgE immuno-adsorbents on two sera from persons sensitive to aspergillus confirmed that the S-TS activity was not due to IgE, and on two sera with negative RAST and negative prick tests to budgerigar serum antigens confirmed that the 24 hr monkey PCA responses were due to IgE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117951     DOI: 10.1111/j.1365-2222.1979.tb00491.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  9 in total

1.  IgG4 response to fur animal allergens among fur workers.

Authors:  J Uitti; H Nordman; L Halmepuro; J Savolainen
Journal:  Int Arch Occup Environ Health       Date:  2004-12-09       Impact factor: 3.015

Review 2.  Skin tests.

Authors:  B Guerin; R D Watson
Journal:  Clin Rev Allergy       Date:  1988

3.  Skin testing and extrinsic allergic alveolitis.

Authors:  C McSharry; S W Banham; P P Lynch; G Boyd
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

Review 4.  Nonreaginic anaphylactic antibodies in man.

Authors:  B F Goodwin
Journal:  Clin Rev Allergy       Date:  1983-06

Review 5.  Deficiency of IgG4: a disorder associated with frequent infections and bronchiectasis that may be familial.

Authors:  D C Heiner; A Myers; C S Beck
Journal:  Clin Rev Allergy       Date:  1983-06

6.  Induction of non-IgE anaphylactic antibodies in dogs.

Authors:  A Willemse; A Noordzij; V P Rutten; W E Bernadina
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Allergen specific IgGd antibodies in dogs with atopic dermatitis as determined by the enzyme linked immunosorbent assay (ELISA).

Authors:  A Willemse; A Noordzij; W E Van den Brom; V P Rutten
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

8.  Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis.

Authors:  Yves T Falanga; Natalia S Chaimowitz; Nicolas Charles; Fred D Finkelman; Nicholas A Pullen; Suzanne Barbour; Kevin Dholaria; Travis Faber; Motunrayo Kolawole; Bernice Huang; Sandra Odom; Juan Rivera; Jason Carlyon; Daniel H Conrad; Sarah Spiegel; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.426

9.  Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation.

Authors:  Hozefa S Bandukwala; Bryan S Clay; Jiankun Tong; Purvi D Mody; Judy L Cannon; Rebecca A Shilling; J Sjef Verbeek; Joel V Weinstock; Julian Solway; Anne I Sperling
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.